Skip Navigation


Glycobiology Advance Access originally published online on June 15, 2005
Glycobiology 2005 15(10):1008-1015; doi:10.1093/glycob/cwi091
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
15/10/1008    most recent
cwi091v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Angulo, J.
Right arrow Articles by Nieto, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Angulo, J.
Right arrow Articles by Nieto, P. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oupjournals.org

Dynamic properties of biologically active synthetic heparin-like hexasaccharides

Jesús Angulo2, Milo Hricovíni3, Margarida Gairi4, Marco Guerrini5, José Luis de Paz2, Rafael Ojeda2, Manuel Martín-Lomas2 and Pedro M. Nieto1,2

2 Grupo de Carbohidratos, Instituto de Investigaciones Químicas, CSIC, Américo Vespucio 49, Isla de la Cartuja, 41092 Sevilla, Spain; 3 Institute of Chemistry, Slovak Academy of Sciences, 845 38 Bratislava, Slovakia; 4 Unitat de RMN, Serveis Cientificotècnics, Universitat de Barcelona, Parc Científic de Barcelona, Josep Samitier 1-5, 08028-Barcelona, Spain; and 5 Institute for Chemical and Biochemical Research "G. Ronzoni", via G. Colombo 81, 20133 Milan, Italy


1 To whom correspondence should be addressed; e-mail: pedro.nieto{at}iiq.csic.es

Received on March 29, 2005; revised on May 16, 2005; accepted on June 7, 2005

A complete study of the dynamics of two synthetic heparin-like hexasaccharides, D-GlcNHSO3-6-SO4-{alpha}-(1->4)-L-IdoA-2-SO4-{alpha}-(1->4)-D-GlcNHSO3-6-SO4-{alpha}-(1->4)-L-IdoA-2-SO4-{alpha}-(1->4)-D-GlcNHSO3-6-SO4-{alpha}-(1->4)-L-IdoA-2-SO4-{alpha}-1->iPr (1) and ->4)-L-IdoA-2-SO4-{alpha}-(1->4)-D-GlcNHAc-6-SO4-{alpha}-(1->4)-L-IdoA-{alpha}-(1->4)-D-GlcNHSO3-{alpha}-(1->4)-L-IdoA-2-SO4-{alpha}-1->iPr (2), has been performed using 13C-nuclear magnetic resonance (NMR) relaxation parameters, T1, T2, and heteronuclear nuclear Overhauser effect (NOEs). Compound 1 is constituted from sequences corresponding to the major polysaccharide heparin region, while compound 2 contains a sequence never found in natural heparin. They differ from each other only in sulphation patterns, and are capable of stimulating fibroblast growth factors (FGFs)-1 induced mitogenesis. Both oligosaccharides exhibit a remarkable anisotropic overall motion in solution as revealed by their anisotropic ratios ({tau} /{tau}||), 4.0 and 3.0 respectively. This is a characteristic behaviour of natural glycosaminoglycans (GAG) which has also been observed for the antithrombin (AT) binding pentasaccharide D-GlcNHSO3-6-SO4-{alpha}-(1->4)-D-GlcA-ß-(1->4)-D-GlcNHSO3-(3,6-SO4)-{alpha}-(1->4)-L-IdoA-2-SO4-{alpha}-(1->4)-D-GlcNHSO3-6-SO4-{alpha}-1->Me (3) (Hricovíni, M., Guerrini, M., Torri, G., Piani, S., and Ungarelli, F. (1995) Conformational analysis of heparin epoxide in aqueous solution. An NMR relaxation study. Carbohydr. Res., 277, 11–23). The motional properties observed for 1 and 2 provide additional support to the suitability of these compounds as heparin models in agreement with previous structural (de Paz, J.L., Angulo, J., Lassaletta, J.M., Nieto, P.M., Redondo-Horcajo, M., Lozano, R.M., Jiménez-Gallego, G., and Martín-Lomas, M. (2001) The activation of fibroblast growth factors by heparin: synthesis, structure and biological activity of heparin-like oligosaccharides. Chembiochem, 2, 673–685; Ojeda, R., Angulo, J., Nieto, P.M., and Martin-Lomas. M. (2002) The activation of fibroblast growth factors by heparin: synthesis and structural study of rationally modified heparin-like oligosaccharides. Can. J. Chem,. 80, 917–936; Lucas, R., Angulo, J., Nieto, P.M., and Martin-Lomas, M. (2003) Synthesis and structural studies of two new heparin-like hexasaccharides. Org. Biomol. Chem., 1, 2253–2266) and biological data (Angulo, J., Ojeda, R., de Paz, J.L., Lucas, R., Nieto, P.M., Lozano, R.M., Redondo-Horcajo, M., Giménez-Gallego, G., and Martín-Lomas, M. (2004) The activation of fibroblast growth factors (FGFs) by glycosaminoglycans: influence of the sulphation pattern on the biological activity of FGF-1. Chembiochem, 5, 55–61). Fast internal motions observed for the less sulphated compound 2, as compared with 1, may be related to their different behavior in stimulating FGF1-induced mitogenic activity.

Key words: anisotropy / FGF interaction / heparan sulphate / heparin / NMR relaxation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Guerrini, S. Guglieri, B. Casu, G. Torri, P. Mourier, C. Boudier, and C. Viskov
Antithrombin-binding Octasaccharides and Role of Extensions of the Active Pentasaccharide Sequence in the Specificity and Strength of Interaction: EVIDENCE FOR VERY HIGH AFFINITY INDUCED BY AN UNUSUAL GLUCURONIC ACID RESIDUE
J. Biol. Chem., September 26, 2008; 283(39): 26662 - 26675.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Hanoulle, A. Melchior, N. Sibille, B. Parent, A. Denys, J.-M. Wieruszeski, D. Horvath, F. Allain, G. Lippens, and I. Landrieu
Structural and Functional Characterization of the Interaction between Cyclophilin B and a Heparin-derived Oligosaccharide
J. Biol. Chem., November 23, 2007; 282(47): 34148 - 34158.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.